Medicare Part D - Medicare Claims To Be Used To Monitor Drugs For Post-Market
Medicare Claims To Be Used To Monitor Drugs For Post-Market Adverse Events (Medical News Today)
The Food and Drug Administration (FDA) recently launched an initiative to use information from Medicare Part D claims to investigate the performance of drugs on the market and rapidly identify potential adverse events. The program, termed the Sentinel Initiative, will allow the FDA to detect post-market problems with drugs as they arise.
Brief Details Options For Improving Medicare Part D Choice, Web Site Provides Health Policy-Related Information (Medical News Today)
"Medicare Part D: Simplifying the Program and Improving the Value of Information for Beneficiaries," Commonwealth Fund: The issue brief details specific options for improving beneficiaries' choices under the Medicare prescription drug benefit through increased standardization.
